AMENDMENT NO. 1 TO SPONSOR SUPPORT AND FORFEITURE AGREEMENTSponsor Support and Forfeiture Agreement • September 5th, 2023 • Anzu Special Acquisition Corp I • Orthopedic, prosthetic & surgical appliances & supplies
This AMENDMENT NO. 1 TO SPONSOR SUPPORT AND FORFEITURE AGREEMENT (this “Amendment”) is entered into as of August 31, 2023, by and among Anzu SPAC GP I LLC, a Delaware limited liability company (the “Sponsor”), Anzu Special Acquisition Corp I, a Delaware corporation (the “SPAC”), and Envoy Medical Corporation, a Minnesota corporation (the “Company”). The Sponsor, the SPAC and the Company are sometimes referred to herein individually as a “party” and, collectively, as the “parties.” Capitalized terms used but not defined elsewhere herein shall have the meanings assigned to them in the Support Agreement (as defined below).
AMENDMENT NO. 2 TO SUBSCRIPTION AGREEMENTSubscription Agreement • September 5th, 2023 • Anzu Special Acquisition Corp I • Orthopedic, prosthetic & surgical appliances & supplies
This AMENDMENT NO. 2 TO SUBSCRIPTION AGREEMENT (this “Amendment”) is entered into as of August 23, 2023, by and between Anzu Special Acquisition Corp I, a Delaware corporation (“Anzu”), and Anzu SPAC GP I LLC (“Sponsor”). The SPAC and Sponsor are sometimes referred to herein individually as a “party” and, collectively, as the “parties.” Capitalized terms used but not defined elsewhere herein shall have the meanings assigned to them in the Subscription Agreement (as defined below).
INDEMNITY AGREEMENTIndemnification & Liability • September 5th, 2023 • Anzu Special Acquisition Corp I • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of [●], 2023 by and between Envoy Medical, Inc. a Delaware corporation (the “Company”), and [D&O] (“Indemnitee”).
ENVOY MEDICAL CORPORATION AMENDMENT NO. 1 TO THE Promissory NOTEPromissory Note • September 5th, 2023 • Anzu Special Acquisition Corp I • Orthopedic, prosthetic & surgical appliances & supplies
This Amendment No. 1 to Promissory Note (this “Amendment”) is entered into by and between GAT Funding, LLC, a Minnesota limited liability company, or its successors or assigns (“Investor”), and Envoy Medical Corporation, a Minnesota corporation (the “Company”) and amends that certain Promissory Note, dated April 14, 2023, issued by the Company to Investor (the “Note”) to increase the maximum principal amount that the Company may borrow from $10,000,000 up to a maximum of $15,000,000 (as further described in the amended Section 2 hereof).
